-
Leveling the Field: How the MFN Could Transform Drug Pricing
Sep 9, 2025, 16:22 PM -
The Burden of Patients With Severe Asthma: A Comparison Between Patients Treated With and Eligible for Monoclonal Antibodies Through a Retrospective Observational Analysis of Italian Real-World Data
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Rozanolixizumab for the Treatment of Generalized Myasthenia Gravis (gMG) in Greece
Sep 9, 2025, 16:22 PM -
Comparative Real-World Effectiveness of Tyrosine Kinase Inhibitors as Induction Therapy for Philadelphia-Positive Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study
Sep 9, 2025, 16:22 PM -
Viable Rate of Return for Social Impact Bonds Supporting Research and Development of Gene Therapies for Rare Conditions
Sep 9, 2025, 16:22 PM -
Impact of Nontransfusion-Dependent Thalassemia on Adult Patients' Health-Related Quality of Life and Work Productivity in the Kingdom of Saudi Arabia and United Arab Emirates
Sep 9, 2025, 16:22 PM -
Assessment Of Parental Knowledge Information-Seeking and Information-Providing Regarding Newborn And Infant Screening Examinations
Sep 9, 2025, 16:22 PM -
The Role of Environmental Evidence in HTA: Comparative Insights Into Global Assessment Frameworks
Sep 9, 2025, 16:22 PM -
AI Models for Predicting Clinical Trial Success: Capabilities and Risks of Pattern-Driven Approaches
Sep 9, 2025, 16:22 PM -
Impact of the Severity of Disease-Related Malnutrition on Healthcare Resource Utilization in Pediatric Patients 1 Year and Older
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Direct Oral Anticoagulants vs. Vitamin K Antagonists in Algeria: A Public Payer Perspective
Sep 9, 2025, 16:22 PM -
Postmarketing Safety Analysis of Nebivolol in Real-World Settings Using Bioinformatics and Disproportionality Analysis With FDA Adverse Event Reporting System (FAERS) Data
Sep 9, 2025, 16:22 PM -
The SISAQOL-IMI Recommendations on Standardizing the Use of Thresholds for Interpretation of Patient-Reported Outcome Results in Cancer Clinical Trials
Sep 9, 2025, 16:22 PM -
Epidemiology Treatment Patterns and Outcomes in Gestational Trophoblastic Neoplasia: A Systematic Literature Review and Gap Analysis
Sep 9, 2025, 16:22 PM -
Utility of Minimum Dataset for Generation of Real-World Data in a Context With Evidence Gaps: The Left Ventricular Assist Devices as Destination Therapy
Sep 9, 2025, 16:22 PM -
The Costs of Loneliness-Related Health Consequences in Finland
Sep 9, 2025, 16:22 PM -
Incidence of Tick-Borne Encephalitis in Germany Comparison of Claims Data With Public Surveillance Data
Sep 9, 2025, 16:22 PM -
Quantifying the Value of Delaying Type 1 Diabetes Progression: A New Cost-Effectiveness Model for Capturing the Value of Delayed Onset
Sep 9, 2025, 16:22 PM -
Effectiveness of Community Health Worker vs. Professional Care in Obesity Management: Preliminary Findings From a SMART Trial
Sep 9, 2025, 16:22 PM -
Level of ICER of Health Economic Assessment in France in 2024
Sep 9, 2025, 16:22 PM
